MyAverix Finance
US · Healthcare
Aktis Oncology, Inc. Common stock (AKTS)
Biotechnology
Aktis Oncology, Inc. Common stock (AKTS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AKTS
Aktis Oncology, Inc. Common stock (AKTS) — FAQ
What is AKTS's P/E ratio?
The price-to-earnings (P/E) ratio for Aktis Oncology, Inc. Common stock (AKTS) is 25.00 (data as of 2026-05-23).
Does Aktis Oncology, Inc. Common stock pay a dividend?
Dividend yield is not available in the current snapshot for Aktis Oncology, Inc. Common stock (AKTS). Check the MyAverix Finance app for the latest dividend data.
What sector is Aktis Oncology, Inc. Common stock in?
Aktis Oncology, Inc. Common stock (AKTS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is AKTS listed on?
AKTS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.